Alector (ALEC) Operating Expenses (2018 - 2026)
Alector (ALEC) posted quarterly Operating Expenses of $26.0 million for Q1 2026, down 46.32% year-over-year from $48.4 million in Q1 2025, and down 43.31% quarter-over-quarter from $45.8 million in Q4 2025.
Alector (ALEC) Operating Expenses (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Operating Expenses for 9 consecutive years, with $26.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses fell 46.32% year-over-year to $26.0 million; the TTM figure through Mar 2026 stood at $154.6 million (down 34.0% YoY), while the FY2025 annual figure was $177.1 million, down 27.9% from the prior year.
- Operating Expenses declined to $26.0 million in Q1 2026 per ALEC's latest filing, from $45.8 million in the prior quarter.
- Across five years, Operating Expenses topped out at $70.4 million in Q2 2022 and bottomed at $26.0 million in Q1 2026.
- Historically, Operating Expenses has averaged $57.0 million across 5 years, with a median of $60.7 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Expenses rose 20.89% — and 2026, when it slumped 46.32%.
- Alector's Operating Expenses stood at $69.9 million in 2022, then decreased by 10.35% to $62.6 million in 2023, then fell by 1.84% to $61.5 million in 2024, then retreated by 25.51% to $45.8 million in 2025, then slumped by 43.31% to $26.0 million in 2026.
- Business Quant data shows ALEC's Operating Expenses at $26.0 million in Q1 2026, $45.8 million in Q4 2025, and $40.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | 27.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.71 Mn |
| Mar 31, 2026 | 25.97 Mn |
| Dec 31, 2025 | 45.80 Mn |
| Sep 30, 2025 | 40.87 Mn |
| Jun 30, 2025 | 42.01 Mn |
| Mar 31, 2025 | 48.37 Mn |
| Dec 31, 2024 | 61.49 Mn |
| Sep 30, 2024 | 63.78 Mn |
| Jun 30, 2024 | 60.69 Mn |
| Mar 31, 2024 | 59.60 Mn |
| Dec 31, 2023 | 62.64 Mn |
| Sep 30, 2023 | 59.69 Mn |
| Jun 30, 2023 | 59.80 Mn |
| Mar 31, 2023 | 66.66 Mn |
| Dec 31, 2022 | 69.88 Mn |
| Sep 30, 2022 | 62.60 Mn |
| Jun 30, 2022 | 70.38 Mn |
| Mar 31, 2022 | 68.60 Mn |
| Dec 31, 2021 | 69.72 Mn |
| Sep 30, 2021 | 56.08 Mn |